Aminaphtone for light bleeding in patients under oral anticoagulation
- PMID: 20648217
- PMCID: PMC2905767
- DOI: 10.2174/1874192401004010146
Aminaphtone for light bleeding in patients under oral anticoagulation
Abstract
Background: Bleeding is a common complication of oral anticoagulation therapy.
Objective: The present study evaluated the use of aminaphtone in patients with minor bleeding while taking warfarin.
Methods: Seven patients suffering from bleeding of the nose and gums, who were taking therapeutic doses of warfarin, were included in the study.
Results: The patients were prescribed 75 mg aminaphtone twice daily. For 5 of these patients the bleeding was controlled within 48 h, for 1, within 96 h and for the other, a satisfactory reduction was obtained.
Conclusion: Patients with minor bleeding during treatment using oral anticoagulation, who are free from risk of other complications, can benefit from the use of aminaphtone as an initial therapeutic option.
Keywords: Aminaphtone; Bleeding; Oral Anticoagulation; Treatment; Warfarin.
References
-
- Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:287S–310S. - PubMed
-
- Godoy JMP, Godoy MF, Ricci O, Ruiz MA. Hipercoagulabilidade e trombose. Rev Bras Hematol Hemoter. 1999;21:127–34.
-
- Nutescu EA, Spyropoulos AC, Cranmer KW. Oral anticoagulation: preparing for change. J Am Med Dis Assoc. 2004;5:2–10. - PubMed
-
- Lopes FO, Campos CAH. Tratado de otorrinolaringologia. Rio de Janeiro:Guanabara Koogan. 1997:194–5.
-
- Silva P, editor. Farmacologia. 5ª. Rio de Janeiro: Guanabara Koogan; 1998. pp. 644–5.
LinkOut - more resources
Full Text Sources